Nirav R Bhakta, MD
Critical Care (Intensivists) · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 2 carriers
- Offices
- 2
- Since medical school
- 20 years
- Stanford University School of Medicine, 2006
Offices
2 locations · University of California San Francisco · Regents of the University of California
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
15 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bhakta’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A102883 · Current
Licensed to practise in California · since 2008 · expires 2027-11-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Critical Care Medicine
- American Board of Internal Medicine - Pulmonary Disease
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$44,422
Medicare paid this office $44,422 for 533 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 24 | $13,502 | $185 |
| Return visit (30+ min) | 102 | $10,360 | $80 |
| Long return visit (40+ min) | 31 | $4,279 | $122 |
| Test to measure expiratory airflow and volume | 295 | $2,401 | $7 |
| New patient visit (60+ min) | 15 | $2,361 | $157 |
See all 12 services
| Critical care, first 30-74 minutes | 24 | $13,502 | $185 |
| Return visit (30+ min) | 102 | $10,360 | $80 |
| Long return visit (40+ min) | 31 | $4,279 | $122 |
| Test to measure expiratory airflow and volume | 295 | $2,401 | $7 |
| New patient visit (60+ min) | 15 | $2,361 | $157 |
| New patient visit (45+ min) | 17 | $1,894 | $111 |
| Test to examine how well the lungs exchange gases | 195 | $1,482 | $7 |
| Test for exercise-induced lung stress | 48 | $991 | $19 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 56 | $988 | $14 |
| Test to determine lung volumes using sensors | 37 | $388 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 34 | $306 | $9 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 12 | $160 | $11 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Artery puncture collection of blood sample | – | – | – | – | 17 | – |
| Insertion of artery tube for blood sampling or infusion through skin | – | 11 | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
533 Original Medicare patients in 2024. Average age 71 · Under 65 19% · 85 and older 9% · Women 51% · Also on Medicaid 33% · Health risk score 2.61. Above the middle of the specialty; the typical critical care (intensivists) clinician is at 2.58.
Conditions among them: High blood pressure 75% · COPD 46% · Coronary heart disease 37% · Diabetes 36% · Chronic kidney disease 34% · Atrial fibrillation 28% · Heart failure 27% · Depression 26% · Cancer 20% · Stroke 10% · Dementia 7%.
The office billed $329,225, Medicare allowed $57,519 and paid $44,422; for 1,121 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 533 | 1,121 | 71 | 2.61 | $329,225 | $44,422 |
| 2023 | 489 | 1,037 | 70 | 2.51 | $378,487 | $48,790 |
| 2022 | 460 | 949 | 71 | 2.45 | $407,340 | $53,843 |
| 2021 | 412 | 900 | 69 | 2.25 | $390,839 | $55,397 |
| 2020 | 379 | 830 | 70 | 2.71 | $413,366 | $58,316 |
| 2019 | 476 | 1,197 | 69 | 2.62 | $345,757 | $49,956 |
| 2018 | 553 | 1,331 | 68 | 2.35 | $327,853 | $48,771 |
| 2017 | 399 | 922 | 68 | 2.63 | $273,230 | $45,089 |
| 2016 | 336 | 789 | 67 | 2.55 | $164,932 | $27,639 |
| 2015 | 245 | 552 | 65 | 2.76 | $140,852 | $24,002 |
| 2014 | 241 | 591 | 66 | 2.58 | $186,508 | $31,223 |
| 2013 | 215 | 552 | 66 | 2.48 | $106,225 | $17,986 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Critical care, first 30-74 minutes | 32 | $19,515 | $189 |
| Return visit (30+ min) | 62 | $6,991 | $81 |
| New patient visit (45+ min) | 47 | $5,243 | $112 |
| New patient visit (60+ min) | 23 | $3,430 | $149 |
| Long return visit (40+ min) | 18 | $2,726 | $114 |
| Test to measure expiratory airflow and volume | 305 | $2,569 | $7 |
| Test to examine how well the lungs exchange gases | 190 | $1,566 | $8 |
| Test for exercise-induced lung stress | 60 | $1,231 | $20 |
| Test to determine lung volumes using sensors | 23 | $237 | $10 |
| Artery puncture collection of blood sample | 16 | $220 | $13 |
2022: 11 services
| Critical care, first 30-74 minutes | 47 | $26,494 | $192 |
| New patient visit (45+ min) | 45 | $5,016 | $111 |
| Return visit (30+ min) | 43 | $3,832 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,395 | $92 |
| Long return visit (40+ min) | 16 | $2,599 | $130 |
| New patient visit (60+ min) | 17 | $2,597 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,917 | $64 |
| Test to measure expiratory airflow and volume | 265 | $1,899 | $6 |
| Test to examine how well the lungs exchange gases | 164 | $1,113 | $7 |
| Test for exercise-induced lung stress | 39 | $692 | $18 |
| Test to determine lung volumes using sensors | 14 | $140 | $10 |
2021: 12 services
| Critical care, first 30-74 minutes | 49 | $22,992 | $193 |
| Return visit (30+ min) | 52 | $6,156 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $6,094 | $92 |
| New patient visit (60+ min) | 21 | $3,493 | $166 |
| New patient visit (45+ min) | 29 | $3,357 | $116 |
| Long return visit (40+ min) | 18 | $2,518 | $120 |
| Test to measure expiratory airflow and volume | 226 | $1,806 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,734 | $64 |
| Short return visit (20+ min) | 19 | $1,482 | $59 |
| Test to examine how well the lungs exchange gases | 135 | $1,072 | $8 |
| Test for exercise-induced lung stress | 36 | $628 | $17 |
| Test to determine lung volumes using sensors | 13 | $142 | $11 |
2020: 11 services
| Critical care, first 30-74 minutes | 65 | $30,237 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $6,113 | $96 |
| Long return visit (40+ min) | 46 | $5,791 | $92 |
| New patient visit (60+ min) | 27 | $3,870 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,415 | $62 |
| Test to measure expiratory airflow and volume | 190 | $1,503 | $7 |
| Return visit (30+ min) | 22 | $1,502 | $65 |
| Test to examine how well the lungs exchange gases | 108 | $860 | $8 |
| Test for exercise-induced lung stress | 28 | $540 | $19 |
| Insertion of artery tube for blood sampling or infusion through skin | 11 | $427 | $39 |
| Test to determine lung volumes using sensors | 21 | $189 | $9 |
2019: 12 services
| Critical care, first 30-74 minutes | 36 | $15,417 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $7,891 | $93 |
| Long return visit (40+ min) | 51 | $6,598 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $4,483 | $65 |
| New patient visit (60+ min) | 23 | $3,091 | $134 |
| Test to measure expiratory airflow and volume | 287 | $2,717 | $7 |
| Return visit (30+ min) | 21 | $1,421 | $65 |
| Test to examine how well the lungs exchange gases | 163 | $1,370 | $8 |
| Test to determine lung volumes using sensors | 105 | $1,102 | $10 |
| Test for exercise-induced lung stress | 43 | $973 | $20 |
| Test to determine lung volumes using gas dilution or washout | 65 | $686 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 25 | $273 | $11 |
2018: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 76 | $15,278 | $89 |
| Critical care, first 30-74 minutes | 20 | $7,096 | $187 |
| Long return visit (40+ min) | 46 | $5,672 | $91 |
| New patient visit (60+ min) | 34 | $4,765 | $140 |
| Test to measure expiratory airflow and volume | 326 | $3,101 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $2,635 | $63 |
| Return visit (30+ min) | 31 | $2,606 | $64 |
| Test to examine how well the lungs exchange gases | 209 | $1,732 | $8 |
| Test to determine lung volumes using sensors | 108 | $1,179 | $11 |
| Test for exercise-induced lung stress | 34 | $635 | $19 |
| Test to determine lung volumes using gas dilution or washout | 57 | $608 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 44 | $487 | $11 |
2017: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $17,911 | $90 |
| Critical care, first 30-74 minutes | 28 | $14,812 | $190 |
| Test to measure expiratory airflow and volume | 233 | $2,006 | $7 |
| Return visit (30+ min) | 18 | $1,229 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,191 | $63 |
| Test to examine how well the lungs exchange gases | 126 | $1,023 | $8 |
| Test to determine lung volumes using gas dilution or washout | 54 | $582 | $11 |
| Test to determine lung volumes using sensors | 49 | $525 | $11 |
| Pulmonary exercise testing | 19 | $478 | $25 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 24 | $262 | $11 |
2016: 9 services
| Critical care, first 30-74 minutes | 29 | $11,446 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $9,753 | $90 |
| Test to measure expiratory airflow and volume | 239 | $2,150 | $7 |
| Test to examine how well the lungs exchange gases | 126 | $1,042 | $8 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $816 | $63 |
| Test to determine lung volumes using sensors | 58 | $643 | $10 |
| Test to determine lung volumes using gas dilution or washout | 53 | $579 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 30 | $344 | $11 |
| Pulmonary exercise testing | 11 | $287 | $26 |
2015: 8 services
| Critical care, first 30-74 minutes | 30 | $11,454 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $5,810 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $2,803 | $65 |
| Test to measure expiratory airflow and volume | 164 | $1,306 | $7 |
| Test to examine how well the lungs exchange gases | 83 | $614 | $7 |
| Test to determine lung volumes using gas dilution or washout | 43 | $432 | $10 |
| Test to determine lung volumes using sensors | 39 | $392 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 19 | $194 | $10 |
2014: 7 services
| Critical care, first 30-74 minutes | 54 | $17,646 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $5,210 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $4,548 | $93 |
| Test to measure expiratory airflow and volume | 138 | $1,023 | $7 |
| Test to determine lung volumes using sensors | 51 | $609 | $10 |
| Test to examine how well the lungs exchange gases | 72 | $524 | $7 |
| Test to determine lung volumes using gas dilution or washout | 43 | $432 | $10 |
2013: 8 services
| Critical care, first 30-74 minutes | 25 | $11,966 | $190 |
| Test to measure expiratory airflow and volume | 157 | $1,303 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $934 | $62 |
| Test to determine lung volumes using sensors | 72 | $887 | $12 |
| Test to examine how well the lungs exchange gases | 88 | $744 | $8 |
| Test to determine lung volumes using gas dilution or washout | 52 | $619 | $12 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 25 | $290 | $12 |
| Test to measure largest amount of air breathed in an out | 23 | $115 | $5 |
Medicaid work
$1,554 in 2024
Medicaid paid $1,554 for 166 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 138 | $1,390 |
| Diffusing capacity | 13 | $120 |
| MEASURE BLOOD OXYGEN LEVEL | 15 | $44 |
| 2024 | 166 | 3 | 27 | $1,554 |
| 2023 | 288 | 3 | 42 | $2,889 |
| 2022 | 308 | 3 | 37 | $14,555 |
| 2021 | 157 | 2 | 31 | $1,187 |
| 2020 | 169 | 3 | 36 | $6,774 |
| 2019 | 183 | 3 | 34 | $3,067 |
| 2018 | 459 | 5 | 61 | $6,573 |
See the largest Medicaid services in earlier years
2023
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 207 | $1,970 |
| Diffusing capacity | 69 | $674 |
| PULMONARY STRESS TESTING | 12 | $245 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 75 | $12,386 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 155 | $1,477 |
| Diffusing capacity | 78 | $692 |
2021
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 125 | $990 |
| Diffusing capacity | 32 | $197 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 29 | $5,603 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 107 | $927 |
| Diffusing capacity | 33 | $245 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 33 | $1,886 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 137 | $1,047 |
| Diffusing capacity | 13 | $134 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 54 | $3,483 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 258 | $1,960 |
| Diffusing capacity | 110 | $694 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 25 | $266 |
| Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes | 12 | $170 |
Drugs they prescribed that Part D paid
$676,476
Pharmacies billed $676,476 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 899) in 2024. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 0%.
236 generic and 663 brand-name prescriptions · $676,476 in drug cost · 27 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofev | 14 | $179,887 | $12,849 |
| Spiriva Respimat | 133 | $88,555 | $666 |
| Dupixent | 20 | $74,540 | $3,727 |
| Tezspire | 17 | $72,916 | $4,289 |
| Trelegy Ellipta | 55 | $55,674 | $1,012 |
See all 25 drugs
| Ofev | 14 | $179,887 | $12,849 |
| Spiriva Respimat | 133 | $88,555 | $666 |
| Dupixent | 20 | $74,540 | $3,727 |
| Tezspire | 17 | $72,916 | $4,289 |
| Trelegy Ellipta | 55 | $55,674 | $1,012 |
| Advair Hfa | 65 | $26,428 | $407 |
| Spiriva Handihaler | 26 | $21,113 | $812 |
| Stiolto Respimat | 39 | $20,977 | $538 |
| Anoro Ellipta | 30 | $15,121 | $504 |
| Symbicort | 37 | $12,638 | $342 |
| Dulera | 28 | $11,012 | $393 |
| Incruse Ellipta | 25 | $8,321 | $333 |
| Budesonide-Formoterol | 17 | $5,031 | $296 |
| Qvar Redihaler | 11 | $3,675 | $334 |
| Fluticasone-Salmeterol | 13 | $3,213 | $247 |
| Breyna | 20 | $3,028 | $151 |
| Albuterol Sulfate Hfa | 67 | $2,374 | $35 |
| Wixela Inhub | 20 | $2,131 | $107 |
| Azelastine | 24 | $854 | $36 |
| Proair Respiclick | 11 | $724 | $66 |
| Ventolin Hfa | 11 | $594 | $54 |
| Azithromycin | 22 | $426 | $19 |
| Fluticasone Propionate | 38 | $425 | $11 |
| Montelukast | 34 | $234 | $7 |
| Prednisone | 28 | $169 | $6 |
Year by year
| 2024 | 899 | 163 | 0% (0) | 74% | $676,476 |
| 2023 | 753 | 130 | 0% (0) | 71% | $434,233 |
| 2022 | 491 | 91 | None | 79% | $313,412 |
| 2021 | 512 | 84 | 0% (0) | 76% | $256,958 |
| 2020 | 609 | 83 | 0% (0) | 77% | $207,054 |
| 2019 | 514 | 81 | None | 79% | $218,223 |
| 2018 | 298 | 65 | 0% (0) | 73% | $82,726 |
| 2017 | 43 | 20 | 0% (0) | 67% | $10,043 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Spiriva Respimat | 121 | $77,902 | $644 |
| Pirfenidone | 12 | $51,818 | $4,318 |
| Dupixent | 14 | $50,093 | $3,578 |
| Symbicort | 84 | $42,357 | $504 |
| Trelegy Ellipta | 34 | $27,891 | $820 |
| Advair Hfa | 32 | $19,583 | $612 |
| Stiolto Respimat | 34 | $16,895 | $497 |
| Spiriva Handihaler | 15 | $12,334 | $822 |
| Incruse Ellipta | 27 | $9,739 | $361 |
| Advair Diskus | 17 | $9,679 | $569 |
| Flovent Hfa | 20 | $8,514 | $426 |
| Anoro Ellipta | 16 | $7,976 | $499 |
| Bevespi Aerosphere | 13 | $5,887 | $453 |
| Wixela Inhub | 18 | $3,707 | $206 |
| Albuterol Sulfate Hfa | 61 | $1,687 | $28 |
| Ventolin Hfa | 23 | $1,483 | $64 |
| Fluticasone Propionate | 26 | $833 | $32 |
| Azelastine | 12 | $612 | $51 |
| Montelukast | 41 | $494 | $12 |
| Prednisone | 19 | $199 | $10 |
| Omeprazole | 14 | $181 | $13 |
| Sulfamethoxazole-Trimethoprim | 16 | $142 | $9 |
| Azithromycin | 14 | $93 | $7 |
2022: 15 drugs
| Spiriva Respimat | 94 | $55,307 | $588 |
| Dupixent | 11 | $40,102 | $3,646 |
| Symbicort | 48 | $23,260 | $485 |
| Stiolto Respimat | 34 | $18,402 | $541 |
| Advair Hfa | 22 | $15,386 | $699 |
| Flovent Hfa | 26 | $12,050 | $463 |
| Trelegy Ellipta | 13 | $8,593 | $661 |
| Incruse Ellipta | 19 | $6,746 | $355 |
| Anoro Ellipta | 12 | $5,717 | $476 |
| Bevespi Aerosphere | 13 | $5,712 | $439 |
| Ventolin Hfa | 21 | $1,452 | $69 |
| Albuterol Sulfate Hfa | 26 | $957 | $37 |
| Fluticasone Propionate | 25 | $518 | $21 |
| Azelastine | 11 | $485 | $44 |
| Montelukast | 14 | $257 | $18 |
2021: 13 drugs
| Spiriva Respimat | 139 | $72,450 | $521 |
| Symbicort | 46 | $27,911 | $607 |
| Advair Hfa | 39 | $21,680 | $556 |
| Stiolto Respimat | 22 | $11,246 | $511 |
| Combivent Respimat | 14 | $6,579 | $470 |
| Flovent Hfa | 19 | $6,479 | $341 |
| Bevespi Aerosphere | 15 | $6,258 | $417 |
| Ventolin Hfa | 23 | $1,772 | $77 |
| Azelastine | 25 | $1,271 | $51 |
| Albuterol Sulfate Hfa | 20 | $1,007 | $50 |
| Azithromycin | 13 | $676 | $52 |
| Fluticasone Propionate | 27 | $526 | $19 |
| Montelukast | 18 | $342 | $19 |
2020: 13 drugs
| Spiriva Respimat | 119 | $62,442 | $525 |
| Advair Hfa | 59 | $30,549 | $518 |
| Symbicort | 53 | $26,732 | $504 |
| Incruse Ellipta | 46 | $18,550 | $403 |
| Flovent Hfa | 34 | $13,109 | $386 |
| Anoro Ellipta | 27 | $11,705 | $434 |
| Qvar Redihaler | 11 | $2,997 | $272 |
| Ventolin Hfa | 36 | $2,360 | $66 |
| Albuterol Sulfate Hfa | 37 | $2,316 | $63 |
| Azelastine | 19 | $945 | $50 |
| Azithromycin | 13 | $795 | $61 |
| Fluticasone Propionate | 33 | $553 | $17 |
| Montelukast | 22 | $469 | $21 |
2019: 13 drugs
| Spiriva Respimat | 73 | $33,636 | $461 |
| Advair Hfa | 52 | $23,233 | $447 |
| Incruse Ellipta | 57 | $19,844 | $348 |
| Symbicort | 44 | $16,510 | $375 |
| Spiriva | 26 | $14,443 | $556 |
| Flovent Hfa | 27 | $13,957 | $517 |
| Anoro Ellipta | 27 | $12,073 | $447 |
| Ventolin Hfa | 31 | $1,980 | $64 |
| Albuterol Sulfate Hfa | 15 | $1,099 | $73 |
| Azithromycin | 13 | $771 | $59 |
| Proair Hfa | 11 | $738 | $67 |
| Fluticasone Propionate | 25 | $330 | $13 |
| Montelukast | 23 | $283 | $12 |
2018: 10 drugs
| Spiriva Respimat | 59 | $23,800 | $403 |
| Symbicort | 36 | $14,146 | $393 |
| Advair Hfa | 21 | $9,396 | $447 |
| Advair Diskus | 17 | $8,165 | $480 |
| Flovent Hfa | 21 | $7,724 | $368 |
| Incruse Ellipta | 15 | $4,762 | $317 |
| Ventolin Hfa | 19 | $1,131 | $60 |
| Proair Hfa | 11 | $665 | $60 |
| Montelukast | 23 | $285 | $12 |
| Fluticasone Propionate | 18 | $263 | $15 |
Money from drug and device companies
$12 in 2020
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Breztri Aerosphere | $12 | 1 payment
|
See the published payment
| AstraZeneca Pharmaceuticals LP | Education · 2020-11-05 | Breztri Aerosphere | $12 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1457523466
- Licence
- CA A102883California A102883: Current · expires 2027-11-30
- Trained
- Stanford University School of Medicine, 2006 · 20 years ago
- Group
- University of California San Francisco · Regents of the University of California
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 275 W Macarthur, Oakland, CA, 94611
- NPI first listed
- 2008-03-31
- NPI last updated
- 2014-09-16
This is when the NPI record was last certified, not a medical board exam.